International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma.
Saved in:
| Title: | International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma. |
|---|---|
| Authors: | Zarba M; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., O'Sullivan D; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada., Maj D; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., Cheung WY; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., Ludwig L; Department of Medical Oncology, IPSEN, Edmonton, AB, Canada., Wells C; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., Ferrier E; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada., El Hajj Chehade R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Donskov F; Department of Medical Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark., Eid M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, Canada., Beuselinck B; Department of Medical Oncology, UZ Leuven, Leuven, Belgium., McKay RR; Department of Medical Oncology, UC San Diego School of Medicine, San Diego, CA, United States., Wood L; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada., Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Suárez C; Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Takemura K; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Duran I; Hospital Universitario Marqués de Valdecilla, IDIVAL Santander, Santander, Spain., Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Heng DY; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada. |
| Source: | Frontiers in oncology [Front Oncol] 2026 May 04; Vol. 16, pp. 1827686. Date of Electronic Publication: 2026 May 04 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1827686 |
